CIRSE Standards of Practice for the Interventional Radiology Management of Acute and Chronic Arterial Mesenteric Ischaemia.

IF 2.8 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

CardioVascular and Interventional Radiology Pub Date : 2025-07-10 DOI:10.1007/s00270-025-04080-0

Romaric Loffroy, Antonio Basile, Edit Dósa, Geert Maleux, Bora Peynircioglu, Olivier Chevallier

{"title":"CIRSE Standards of Practice for the Interventional Radiology Management of Acute and Chronic Arterial Mesenteric Ischaemia.","authors":"Romaric Loffroy, Antonio Basile, Edit Dósa, Geert Maleux, Bora Peynircioglu, Olivier Chevallier","doi":"10.1007/s00270-025-04080-0","DOIUrl":null,"url":null,"abstract":"Purpose: Mesenteric ischaemia due to arterial occlusion, usually secondary to atherosclerosis or arterial thromboembolism, may be acute or chronic. Endovascular intervention is now the primary treatment based on its minimally invasive nature and lower in-hospital mortality. Open surgery is indicated in the presence of bowel necrosis, the diagnosis of which remains challenging. This document makes best-practice recommendations about the interventional radiology management of acute and chronic mesenteric ischaemia.Methods: The CIRSE Standards of Practice Committee established a writing group of six clinicians with internationally recognised expertise in the management of arterial mesenteric ischaemia. The writing group performed a pragmatic search on PubMed for relevant studies published in English in 2013-2024. The final recommendations were developed by consensus.Results: Endovascular interventions for arterial mesenteric ischaemia have very high technical success rates. Complication rates are lower than with open surgical revascularisation; however, patency times may be shorter. Patients must receive antiplatelet therapy and be monitored for recurrence.","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CardioVascular and Interventional Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00270-025-04080-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Mesenteric ischaemia due to arterial occlusion, usually secondary to atherosclerosis or arterial thromboembolism, may be acute or chronic. Endovascular intervention is now the primary treatment based on its minimally invasive nature and lower in-hospital mortality. Open surgery is indicated in the presence of bowel necrosis, the diagnosis of which remains challenging. This document makes best-practice recommendations about the interventional radiology management of acute and chronic mesenteric ischaemia.

Methods: The CIRSE Standards of Practice Committee established a writing group of six clinicians with internationally recognised expertise in the management of arterial mesenteric ischaemia. The writing group performed a pragmatic search on PubMed for relevant studies published in English in 2013-2024. The final recommendations were developed by consensus.

Results: Endovascular interventions for arterial mesenteric ischaemia have very high technical success rates. Complication rates are lower than with open surgical revascularisation; however, patency times may be shorter. Patients must receive antiplatelet therapy and be monitored for recurrence.

查看原文本刊更多论文

急性和慢性动脉性肠系膜缺血介入放射学治疗实践标准。

目的：动脉闭塞引起的肠系膜缺血，通常继发于动脉粥样硬化或动脉血栓栓塞，可急性或慢性。基于其微创性和较低的住院死亡率，血管内介入治疗是目前的主要治疗方法。开放性手术是指肠坏死的存在，其诊断仍然具有挑战性。本文对急性和慢性肠系膜缺血的介入放射学治疗提出了最佳实践建议。方法：CIRSE实践标准委员会成立了一个由6名具有国际公认的动脉肠系膜缺血管理专业知识的临床医生组成的写作小组。写作小组在PubMed上对2013-2024年发表的相关英文研究进行了语用搜索。最后的建议是协商一致拟订的。结果：血管内介入治疗动脉性肠系膜缺血技术成功率高。并发症发生率低于开放手术血运重建术；然而，申请时间可能会更短。患者必须接受抗血小板治疗并监测复发情况。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

CardioVascular and Interventional Radiology 医学-核医学

CiteScore

5.50

自引率

13.80%

发文量

306

审稿时长

3-8 weeks

期刊介绍： CardioVascular and Interventional Radiology (CVIR) is the official journal of the Cardiovascular and Interventional Radiological Society of Europe, and is also the official organ of a number of additional distinguished national and international interventional radiological societies. CVIR publishes double blinded peer-reviewed original research work including clinical and laboratory investigations, technical notes, case reports, works in progress, and letters to the editor, as well as review articles, pictorial essays, editorials, and special invited submissions in the field of vascular and interventional radiology. Beside the communication of the latest research results in this field, it is also the aim of CVIR to support continuous medical education. Articles that are accepted for publication are done so with the understanding that they, or their substantive contents, have not been and will not be submitted to any other publication.